儿童紫癜性肾炎治疗进展

Abstract

Abstract: Henoch-Sch?nlein purpura nephritis (HSPN) is the most common secondary glomerular disease in children. The clinical manifestations of HSPN vary from microscopic hematuria, microalbuminuria to renal dysfunction even end stage renal disease which is needed to rely on long-term renal replacement therapy, thus affecting the quality of children life seriously. In recent years, the incidence of Henoch-Sch?nlein purpura continues to increase, which should be paid more attention. There are many studies about the treatment of HSPN both at home and abroad, yet no certain conclusion is drawn because of the inconsistent results. We advocate stepped therapies, that is, the appropriate regimens are chosen based on the clinical manifestations and renal pathology in children. For severe HSPN, we recommend multi-drug intensive therapy combined with other methods such as plasma exchange to alleviate the symptoms.

Reviewer:YE Lezhen,ZHOU Jiangjin . Progress in treatment of pediatric Henoch-Sch?nlein purpura nephritis　[J]., 2014, 32(4): 392-395.

References

[1] Wilhelm-Bals A，Chehade H，Girardin E. Henoch-Sch?nlein Purpura a dual follow up between pediatrician and pediatric nephrologist [J].Rev Med suisse，2011，7(283)：442-446.
[2] Assadi F. Childhood Henoch-Schonlein nephritis：a multivariate analysis of clinical features and renal morphology at disease onset [J]. Iran J Kidney Dis，2009，3(1)：17-21.
[3] Tizard EJ. Henoch-Sch?nlein Purpura [J]. Arch Dis Child，1999，80(4)：380-383.
[4] Narchi H. Risk of long term renal impairment and duration of follow up recommendedfor Henoch-Sch?nlein purpura with normal or minimal urinary findings：a systematic review [J]. Arch Dis Child，2005，90(9)：916-920.
[5] Chang WL，Yang YH，Wang LC，et al. Renal manifestions in Henoch-Sch?nlein purpura：a10-year clinical study [J]. Pediatr Nephrol，2005，20(9)：1269-1272.
[6] Shin JI，Park JM，Shin YH，et al. Predictive factors for nephritis，relapse，and significant proteinuria in childhood Henoch-Sch?nlein purpura [J]. Scand J Rheumatol，2006，35(1)：56-60.
[7] Zhou TB，Ou C，Qin YH，et al. A meta-analysis of the association between angiotensin- converting enzyme insertion/deletion gene polymorphism and Henoch-Sch?nlein purpura nephritis risk in Asian children [J]. Clin Exp Rheumatol，2012，30(2)：315-316.
[8] Tabel Y，Mir S，Berdeli A. Interleukin 8 gene 2767 A/G polymorphism is associated with increased risk of nephritis in children with Henoch-Sch?nlein purpura [J]. Rheumat ol Int，2012，32(4)：941-947.
[9] Wang JJ，Shi YP，Huang Y，et al. Association of tumor necrosis factor-alpha gene polymorphisms with Henoch-Schonlein purpura nephritis in children [J]. Zhongguo Dang Dai Er Ke Za Zhi，2013，15(2)：88-90.
[10] He X，Yu C，Zhao P，et al. The genetics of Henoch-Sch?nlein purpura：a systematic review and meta-analysis [J]. Rheumatol Int，2013，33(6)：1387-1395.
[11] Zhou TB，Yin SS. Association of matrix metalloproteinase-9 level with the risk of renalInvolvement for Henoch-Sch?nlein purpura in children [J]. Ren Fail2013，35(3)：425-429.
[12] 中华医学会儿科学分会肾脏病组.紫癜性肾炎的诊治循证指南(试行) [J]. 中华儿科杂志，2009，47（12）：911-913.
[13] Rai A，Nast C，Adler S. Henoch-Schonlein purpura nephritis[J] .J Am Soc Nephol，1999，10(12)：2637-2644.
[14] Radhakrishnan J, Cattran DC. The Kdigo practice guideline on glomerulonephritis：reading between the (guide)lines--application to the individual patient [J]. Kidney Int，2012，82(8) ：840-856.
[15] Floege J，Feehally J. Treatment of IgA nephropathy and Henoch-Sch?nlein nephritis [J]. Nat Rev Nephrol，2013，9(6)：320-327.
[16] Ronkainen J，Koskimies O，Ala-Houhala M，et al. Early prednisone therapy in Henoch- Sch?nlein purpura：a randomized，double-blind，placebo-controlled trial [J]. J Pediatr.2006，149(2)：241-247.
[17] Trapani S，Micheli A，Grisolia F，et al. Henoch Sch?nlein purpura in childhood：epidemiogical and clinical analysis of 150 cases over a 5-year period and review of literature [J]. Semin Arthritis Rheum，2005，35(3)：143-153.
[18] Dudley J，Smith G，Llewelyn-Edwards A，et al. Randomised，double-blind，placebo-controlled trial to determine whether steroids reduce the incidence and severity of nephropathy in Henoch-Sch?nlein Purpura(HSP) [J]. Arch Dis Child, 2013，98(10)：756-763.
[19] Jauhola O，Ronkainen J，Koskimies O，et al. Outcome of Henoch-Sch?nlein purpura 8 years after treatment with a placebo or prednisone at disease onset [J]. Pediatr Nephrol, 2012，27(6)：933-939.
[20] Kawasaki Y，Suzuki J，Suzuki H. Efficacy of methylprednisolone and urokinase pulse therapy combined with or without cyclophosphamide in severe Henoch-Sch?nlein nephritis：a clinical and histopathological study [J]. Nephrol Dial Transplant，2004，19(4)：858-864.
[21] Tarshish P，Bernstein J，Edelmann CM. Henoch-Sch?nlein purpura nephritis：course of diease and efficacy of cyclophosphamide [J]. Pediatr Nephrol，2004，19(1)：51-56.
[22] Davin JC，Coppo R. Pitfalls in recommending evidence-based guidelines for a protean disease like Henoch-Sch?nlein purpura nephritis [J]. Pediatr Nephrol，2013，28(10)：1897-1903.
[23] Nikibakhsh AA，Mahmoodzadeh H，Karamyyar M，et al. Treatment of complicated henoch-sch?nlein purpura with mycophenolate mofetil：a retrospective case series report [J]. Int J Rheumatol，2010，2010：254-316.
[24] Du Y，Hou L，Zhao C，et al. Treatment of children with Henoch-Sch?nlein purpura nephritis with mycophenolate mofetil [J]. Pediatr Nephrol，2012，27(5)：765-771.
[25] Kawasaki Y，Suyama K，Hashimoto K，et al. Methylprednisolone pulse plus mizoribine in children with Henoch-Sch?enlein purpura nephritis [J]. Clin Rheumatol，2011，30(4)：529-535.
[26] Kawasaki Y. Mizoribine：a new approach in the treatment of renal disease [J]. Clin Dev Immunol，2009，2009：681482
[27] 黄松明，李秋，郭艳芳.紫癜性肾炎的诊治：《儿童常见肾脏疾病诊治循证指南(试行)》解读(二) [J]. 中华儿科杂志，2009，47(12)：914-916.
[28] Jauhola O，Ronkainen J，Autio-Harmainen H，et al. Cyclosporine A vs. methylprednisolone for Henoch-Sch?nlein nephritis：a randomized trial [J]. Pediatr Nephrol，2011，26(12)：2159-2166.
[29] Park JM，Won SC，Shin JI，et al.Cyclosporin a therapy for Henoch-Sch?nlein nephritis with nephrotic-range proteinuria [J]. Pediatr Nephrol，2011，26(3)：411-417.
[30] Ninchoji T，Kaito H，Nozu K，et al. Treatment strategies for Henoch-Sch?nlein purpura nephritis by histological and clinical severity [J]. Pediatr Nephrol，2011，26(4)：563-569.
[31] ALtugan FS，Ozen S，Aktay-Ayaz N，et al.T reatment of severe Henoch-Sch?nlein nephritis：justifying more immunosuppression [J]. Turk J Pediatr，2009，51(6)：551-555.
[32] Kawasaki Y. The pathogenesis and treatment of pediatric Henoch－Sch?nlein purpura nephritis [J]. Clin Exp Nephrol，2011，15(5)：648-657.
[33] Jayne DR，Gaskin G，Rasmussen N，et al. Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis [J]. J Am Soc Nephrol，2007，18(7)：2180-2188.
[34] Shiny M，Ognjanovic MV，Coulthard MG. Treating severe Henoch-Sch?nlein and IgA nephritis with plasmapheresis alon [J]. Pediatr Nephrol，2007，22(8)：1167-1171.
[35] Ohara S，Kawasaki Y，Matsuura H，et al. Successful therapy with tonsillectomy for severe ISKDC grade VI Henoch-Sch?nlein purpura nephritis and persistent nephrotic syndrome [J]. Clin Exp Nephrol，2011，15(5)：749-753.
[36] Inoue CN，Nagasaka T，Matsutani S，et al. Efficacy of early dental and ENT therapy in preventing nephropathy in pediatric Henoch-Sch?nlein purpura [J]. Clin Rheumatol，2008，27(12)：1489-1496.
[37] Davin JC. Henoch-Sch?nlein purpura nephritis and Pathophysiology，Treatment and Future Strategy [J]. Clin J Am Soc Nephrol，2011，6(3)：679-689.
[38] Kawasaki Y，Ono A，Ohara S，et al. Henoch-sch?nlein purpura nephritis in childhood：pathogennesis，prognostic factors and treatment [J]. Fukushima J Med Sci，2013，59(1)：15-26.
[39] Halling SF，S?derberg MP，Berg UB. Henoch Sch?nlein nephritis：clinical findings related to renal function and morphology [J]. Pediatr Nephrol，2005，20(1)：46-51.

Progress in treatment of pediatric Henoch-Sch?nlein purpura nephritis

PDF (PC)

Like

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 0

Metrics

Comments

Recommended 0